WSU research sheds new light on a molecule that may be used to treat heart conditions that can lead to stroke, heart attack and other forms of heart disease.
The WSU discovery may also set the stage for future treatment strategies for sleep disorders, neurological diseases and other conditions associated with troubled sleep.
The Center will have the capacity to address infectious disease outbreaks in eastern and central Africa. It is made possible by $7.6 million in funding over five years from the U.S. National Institute of Allergy and Infectious Diseases.
The research could ultimately help scientists better understand how COVID‑19 affects the health and immune responses of mothers and babies, and whether infant feeding practices play a role.
A research team led by WSU and Universidad del Valle de Guatemala scientists found clear indicators for how poor hygiene and antibiotic use contribute to colonization of antimicrobial-resistant bacteria.
Arliegh Cayanan, a fourth-year College of Pharmacy and Pharmaceutical Sciences student, will serve as the next student regent on the WSU Board of Regents.
The COVID Urban Rural Explorer is one of the first tools that enables users to identify rural counties across the country with both limited hospital capacity and where COVID‑19 cases are rapidly growing.